UNION CITY, Calif., Sept. 18 /PRNewswire-FirstCall/ -- Abaxis, Inc. (NASDAQ:ABAX), a medical products company manufacturing point-of-care blood analysis systems, announced today that Clint Severson, CEO and President, will present at the 2007 UBS Global Life Science Conference on Thursday, September 27, 2007 at 12:00 p.m. Eastern Time at the Grand Hyatt in New York City.
Interested parties can access the webcast of the presentation at http://www.ibb.ubs.com/. Click on the conferences icon, then click on the 2007 Global Life Sciences Conference event and the follow the link for the webcast. The replay will be available 3 hours after the actual presentation time, and will be accessible until October 27, 2007.
About Abaxis Abaxis develops, manufactures and markets portable blood analysis systems for use in any veterinary or human patient-care setting to provide clinicians with rapid blood constituent measurements. The system consists of a compact, 5.1 kilogram (11.2 pounds), portable analyzer and a series of single-use plastic discs, called reagent discs that contain all the chemicals required to perform a panel of up to 13 tests on veterinary patients and 14 tests on human patients. The system can be operated with minimal training and performs multiple routine tests on whole blood, serum or plasma samples. The system provides test results in less than 12 minutes with the precision and accuracy equivalent to a clinical laboratory analyzer. The veterinary business also provides to the veterinarian and research market a line of hematology instruments for point of care complete blood counts (CBC).
Contact: Clint Severson Lytham Partners, LLC
Chief Executive Officer Joe Dorame, Joe Diaz & Robert Blum
ABAXIS, Inc. 602-889-9700
510-675-6500
DATASOURCE: Abaxis, Inc.
CONTACT: Clint Severson, Chief Executive Officer of ABAXIS, Inc., +1-510-675-6500; Joe Dorame, Joe Diaz & Robert Blum, all of Lytham Partners, LLC, +1-602-889-9700, for Abaxis, Inc. |